Lutein and zeaxanthin are the ONLY carotenoids that accumulate in the macula — they're actively transported there by specific binding proteins (StARD3 for lutein, GSTP1 for zeaxanthin). Once in the macula, they serve two functions: (1) absorbing blue light (400-500nm) before it reaches photoreceptors — acting as internal sunglasses — and (2) quenching reactive oxygen species generated by light exposure. The macula has the highest metabolic rate per gram of any tissue in the body, making it exceptionally vulnerable to oxidative damage. Lutein also accumulates in the brain, where it comprises 60-70% of total brain carotenoids despite being only 12% of circulating carotenoids, suggesting active preferential uptake.
No significant drug interactions have been identified in clinical literature. Lutein and zeaxanthin are naturally occurring dietary carotenoids with no known pharmacological interactions. They may compete with beta-carotene for absorption (hence the AREDS2 switch from beta-carotene to lutein).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.